STOCK TITAN

Marex announces share purchases by Directors and Officers

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags

Marex (NASDAQ: MRX) announced that directors and officers purchased ordinary shares in the open market between October 10–14, 2025. Key purchases include CEO Ian Lowitt buying 32,465 shares (total 2,615,016), Paolo Tonucci buying 30,000 shares (total 1,108,342), Non-Executive Chairman Robert Pickering buying 2,700 shares (total 20,594) and Board member Konstantin Graf von Schweinitz buying 7,100 shares (total 14,993). Former board members Sir Jeremy Isaacs and Roger Nagioff each bought 35,000 shares.

Management says the purchases reflect confidence in Marex’s growth trajectory and notes the executive leadership team collectively owns more than 7% of the company.

Marex (NASDAQ: MRX) ha annunciato che i membri del consiglio e gli ufficiali hanno acquistato azioni ordinarie sul mercato aperto tra il 10 e il 14 ottobre 2025. Gli acquisti chiave includono il CEO Ian Lowitt che ha acquistato 32.465 azioni (totale 2.615.016), Paolo Tonucci che ha acquistato 30.000 azioni (totale 1.108.342), il presidente non esecutivo Robert Pickering che ha acquistato 2.700 azioni (totale 20.594) e il membro del consiglio Konstantin Graf von Schweinitz che ha acquistato 7.100 azioni (totale 14.993). Ex membri del consiglio Sir Jeremy Isaacs e Roger Nagioff hanno acquistato ciascuno 35.000 azioni.

La direzione afferma che gli acquisti riflettono fiducia nel percorso di crescita di Marex e osserva che il team dirigenziale possiede collettivamente più del 7% della società.

Marex (NASDAQ: MRX) anunció que directores y ejecutivos compraron acciones ordinarias en el mercado abierto entre el 10 y el 14 de octubre de 2025. Las compras clave incluyen el CEO Ian Lowitt comprando 32.465 acciones (total 2.615.016), Paolo Tonucci comprando 30.000 acciones (total 1.108.342), el presidente no ejecutivo Robert Pickering comprando 2.700 acciones (total 20.594) y el miembro del consejo Konstantin Graf von Schweinitz comprando 7.100 acciones (total 14.993). Antiguos miembros del consejo Sir Jeremy Isaacs y Roger Nagioff compraron cada uno 35.000 acciones.

La dirección afirma que las compras reflejan confianza en la trayectoria de crecimiento de Marex y señala que el equipo directivo en conjunto posee más del 7% de la compañía.

Marex (NASDAQ: MRX)는 이사와 임원이 2025년 10월 10일부터 14일까지 공개시장에서 보통주를 매수했다고 발표했다. 주요 매수로는 CEO Ian Lowitt가 32,465주를 매수(총 2,615,016주), Paolo Tonucci가 30,000주를 매수(총 1,108,342주), 비상임 회장 Robert Pickering이 2,700주를 매수(총 20,594주), 그리고 이사회 이사 Konstantin Graf von Schweinitz가 7,100주를 매수(총 14,993주)이다. 전 이사 Sir Jeremy Isaacs와 Roger Nagioff도 각각 35,000주를 매수했다.

경영진은 매수가 Marex의 성장 궤도에 대한 신뢰를 반영하며 경영진이 공동으로 회사의 7% 이상를 보유하고 있다고 언급했다.

Marex (NASDAQ: MRX) a annoncé que des administrateurs et des dirigeants ont acheté des actions ordinaires sur le marché libre entre le 10 et le 14 octobre 2025. Les principaux achats incluent le PDG Ian Lowitt achetant 32 465 actions (au total 2 615 016), Paolo Tonucci achetant 30 000 actions (au total 1 108 342), le président non exécutif Robert Pickering achetant 2 700 actions (au total 20 594) et le membre du conseil Konstantin Graf von Schweinitz achetant 7 100 actions (au total 14 993). Ancien(s) administrateur(s) Sir Jeremy Isaacs et Roger Nagioff ont chacun acheté 35 000 actions.

La direction indique que les achats reflètent la confiance dans la trajectoire de croissance de Marex et note que l'équipe de direction possède collectivement plus de 7% de la société.

Marex (NASDAQ: MRX) gab bekannt, dass Direktoren und leitende Angestellte zwischen dem 10. und 14. Oktober 2025 ordinary shares am offenen Markt kauften. Zu den wichtigsten Käufen gehören CEO Ian Lowitt, der 32.465 Aktien kaufte (insgesamt 2.615.016), Paolo Tonucci, der 30.000 Aktien kaufte (insgesamt 1.108.342), der nicht geschäftsführende Vorsitzende Robert Pickering, der 2.700 Aktien kaufte (insgesamt 20.594) und das Vorstandsmitglied Konstantin Graf von Schweinitz, das 7.100 Aktien kaufte (insgesamt 14.993). Ehemalige Vorstandsmitglieder Sir Jeremy Isaacs und Roger Nagioff kauften jeweils 35.000 Aktien.

Das Management sagt, dass die Käufe Vertrauen in Marex’ Wachstumskurs widerspiegeln, und stellt fest, dass das Führungsteam gemeinsam mehr als 7% des Unternehmens besitzt.

Marex (بورصة ناسداك: MRX) أعلنت أن المديرين والضباط اشتروا أسهم عادية في السوق المفتوح بين 10 و14 أكتوبر 2025. تشمل المشتريات الرئيسية المدير التنفيذي إيان لوِيت الذي اشترى 32,465 سهماً (إجمالي 2,615,016)، Paolo Tonucci الذي اشترى 30,000 سهم (إجمالي 1,108,342)، رئيس مجلس الإدارة غير التنفيذي روبرت بيكرينغ الذي اشترى 2,700 سهم (إجمالي 20,594) وعضو مجلس الإدارة كونستانتين غراف فون شوفيينتز الذي اشترى 7,100 سهم (إجمالي 14,993). كما اشترى أعضاء المجلس السابقون السير جيريمي إيزاكس وروجر ناجيوف 35,000 سهم لكل منهما.

قالت الإدارة إن هذه المشتريات تعكس الثقة في مسار نمو Marex وأشارت إلى أن فريق القيادة يملك مجتمعياً أكثر من 7% من الشركة.

Marex (NASDAQ: MRX) 公布董事和高管在2025年10月10日至14日期间于公开市场购买普通股。主要购买包括 CEO Ian Lowitt 购买了32,465股(总计2,615,016股)、Paolo Tonucci 购买了30,000股(总计1,108,342股)、非执行主席 Robert Pickering 购买了2,700股(总计20,594股)以及 董事会成员 Konstantin Graf von Schweinitz 购买了7,100股(总计14,993股)。前董事 Sir Jeremy Isaacs 和 Roger Nagioff 各自购买了35,000股。

管理层表示这些购买反映了对 Marex 增长轨迹的信心,并指出管理团队合计拥有公司超过7%的股份

Positive
  • CEO Ian Lowitt purchased 32,465 shares, raising his holding to 2,615,016 shares
  • Paolo Tonucci purchased 30,000 shares, raising his holding to 1,108,342 shares
  • Sir Jeremy Isaacs and Roger Nagioff each purchased 35,000 shares in open market
  • Executive leadership now owns more than 7% of Marex outstanding shares
Negative
  • None.

Insights

Significant insider purchases by senior leaders signal aligned incentives and a modestly positive governance signal.

Several senior executives and former board members bought ordinary shares in open market trades on October 10, 2025, October 13, 2025 and October 14, 2025, increasing their individual holdings and with the leadership team now owning > 7% of the company. Open-market purchases by the CEO and other senior officers function as a direct alignment of management and shareholder interests and provide a transparent, measurable endorsement of the company at current public prices.

The immediate dependency is liquidity and timing: these are secondary-market buys, not primary issuances or material corporate actions. The disclosures include a forward-looking cautionary statement that limits inferential reach. Key risks remain unchanged by these trades and continue to depend on operational and financial performance rather than ownership gestures.

Monitor confirmed ownership totals and any follow-up scheduled disclosures around quarterly results, particularly the preliminary third-quarter update mentioned alongside the purchases. Watch for more insider activity before or after the company’s next formal results as a short-term horizon signal; over the medium term, verify whether share accumulation materially alters board alignment or voting blocs.

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (“Marex”; NASDAQ: MRX), the diversified global financial services platform, today announced that directors and officers have purchased ordinary shares in Marex in the open market.

As previously disclosed, on Friday, October 10, Chief Executive Officer Ian Lowitt acquired 32,465 ordinary shares in Marex, increasing his total holding to 2,615,016 ordinary shares. Additionally, on Monday, October 13, Paolo Tonucci, Chief Strategist and Chief Executive Officer of Capital Markets, purchased 30,000 ordinary shares, bringing his total holdings to 1,108,342 ordinary shares.

These purchases are in addition to those made in August by Marex’s Non-Executive Chairman Robert Pickering, and Board member and Risk Committee Chair Konstantin Graf von Schweinitz. Robert bought 2,700 ordinary shares, bringing his holding to 20,594 ordinary shares, and Konstantin bought 7,100 ordinary shares, raising his ownership to 14,993 ordinary shares.

Additionally, on Tuesday, October 14, Sir Jeremy Isaacs and Roger Nagioff – both former Marex Board members and founding partners of JRJ Group, previously a majority shareholder of Marex – also acquired ordinary shares in the open market in a personal capacity. Sir Jeremy purchased 35,000 ordinary shares and Roger acquired 35,000 ordinary shares.

Ian Lowitt, Chief Executive Officer, commented:

“As I stated in our recent preliminary third-quarter update, we are excited about Marex’s prospects. The acquisition of additional shares reflects our strong belief in Marex’s growth trajectory and its future potential. Collectively, the executive leadership team owns more than 7% of the company, underscoring our confidence in the franchise we’ve built.”

Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, our expected growth trajectory and future potential. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions.

These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation: our actual financial results for the third quarter 2025 may differ from our preliminary estimates; subdued commodity market activity or pricing levels; the effects of geopolitical events, terrorism and wars, such as the effect of Russia’s military action in Ukraine or the ongoing conflict in the Middle East, on market volatility, global macroeconomic conditions and commodity prices; changes to the U.S regulatory regime, including with respect to tariffs; changes in interest rate levels; the risk of our clients and their related financial institutions defaulting on their obligations to us; regulatory, reputational and financial risks as a result of our international operations; software or systems failure, loss or disruption of data or data security failures; an inability to adequately hedge our positions and limitations on our ability to modify contracts and the contractual protections that may be available to us in OTC derivatives transactions; market volatility, reputational risk and regulatory uncertainty related to commodity markets, equities, fixed income, foreign exchange; the impact of climate change and the transition to a lower carbon economy on supply chains and the size of the market for certain of our energy products; the impact of changes in judgments, estimates and assumptions made by management in the application of our accounting policies on our reported financial condition and results of operations; lack of sufficient financial liquidity; if we fail to comply with applicable law and regulation, we may be subject to enforcement or other action, forced to cease providing certain services or obliged to change the scope or nature of our operations; significant costs, including adverse impacts on our business, financial condition and results of operations, and expenses associated with compliance with relevant regulations; and if we fail to remediate the material weaknesses we identified in our internal control over financial reporting or prevent material weaknesses in the future, the accuracy and timing of our financial statements may be impacted, which could result in material misstatements in our financial statements or failure to meet our reporting obligations and subject us to potential delisting, regulatory investigations or civil or criminal sanctions, and other risks discussed under the caption “Risk Factors” in our Annual Report on Form 20-F for the year ended 31 December 2024 filed with the Securities and Exchange Commission (the “SEC”) as updated by our other reports filed with the SEC.

The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

About Marex
Marex Group plc (NASDAQ: MRX) is a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. The Group provides comprehensive breadth and depth of coverage across four core services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to 60 exchanges. The Group provides access to the world’s major commodity markets, covering a broad range of clients that include some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 40 offices worldwide, the Group has over 2,400 employees across Europe, Asia and the Americas. For more information visit www.marex.com.

Enquiries please contact:
Marex: Nicola Ratchford / Adam Strachan
+44 778 654 8889 / +1 914 200 2508
nratchford@marex.com / astrachan@marex.com

FTI Consulting US / UK
+1 716 525 7239 / +44 7976870961
marex@fticonsulting.com


FAQ

What shares did Marex CEO Ian Lowitt buy on October 10, 2025 (MRX)?

Ian Lowitt bought 32,465 ordinary shares on October 10, 2025, raising his total to 2,615,016 shares.

How many shares did Paolo Tonucci buy in Marex (MRX) on October 13, 2025?

Paolo Tonucci purchased 30,000 ordinary shares on October 13, 2025, bringing his total to 1,108,342 shares.

Which former Marex board members bought MRX shares in October 2025 and how many?

Former board members Sir Jeremy Isaacs and Roger Nagioff each bought 35,000 ordinary shares in the open market.

What does the insider buying mean for Marex shareholders (MRX)?

Company executives stated the purchases reflect confidence in Marex’s growth trajectory; executives now own over 7% of the company.

When were the director and officer share purchases disclosed for MRX?

The purchases were disclosed in a press release dated October 15, 2025 covering buys from October 10–14, 2025.
Marex Group plc

NASDAQ:MRX

MRX Rankings

MRX Latest News

MRX Latest SEC Filings

MRX Stock Data

2.27B
54.86M
24.78%
69.57%
3.33%
Capital Markets
Financial Services
Link
United Kingdom
London